IDT Australia Limited (AU:IDT)
ASX:IDT
Want to see AU:IDT full AI Analyst Report?
IDT Stock Chart & Stats
AU$0.05
>-AU$0.01(-1.87%)
At close: 4:00 PM EST
AU$0.05
>-AU$0.01(-1.87%)
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.11
Previous CloseN/A
Volume22.00K
Average Volume (3M)336.94K
Market Cap
AU$16.45M
Enterprise ValueAU$24.60M
Total Cash (Recent Filing)AU$1.93M
Total Debt (Recent Filing)AU$9.86M
Price to Earnings (P/E)―
Beta1.42
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding427,425,570
10 Day Avg. Volume373,970
30 Day Avg. Volume336,941
Financial Highlights & Ratios
PEG Ratio-0.21
Price to Book (P/B)1.73
Price to Sales (P/S)1.92
P/FCF Ratio-5.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
CDMO Fee-for-service Business ModelA contract development and manufacturing (CDMO) fee-for-service model generates recurring, contract-driven revenue and reduces product development risk. Over months, this supports predictable throughput and capacity planning, letting IDT monetize manufacturing assets without single-product concentration.
Modest Consistent Revenue GrowthConsistent modest revenue expansion indicates underlying demand for IDT's services and improved utilization of manufacturing capacity. Over a 2–6 month horizon, steady top-line growth can help stabilize margins and justify incremental operational investment in technical services and batch production.
Stable Equity Ratio And Asset BaseA stable equity ratio signals a relatively solid asset base to back operations and manufacturing facilities. For a capital-intensive CDMO, this provides balance-sheet cushioning, supports continued production, and preserves borrowing capacity for equipment or working capital over the medium term.
Bears Say
Negative Operating And Free Cash FlowPersistent negative operating and free cash flows constrain liquidity and the ability to fund working capital, maintenance or growth without external financing. Over several months this increases refinancing risk, can force deferred capex or higher borrowing costs, and weakens operational resilience.
Ongoing Losses And Weak MarginsContinued negative net profit and declining gross margins indicate structural margin pressure from cost or pricing dynamics. Sustained losses erode equity and limit reinvestment, making it harder to scale services profitably and reducing capacity to absorb demand volatility over the medium term.
Rising Leverage And Negative ROEAn increasing debt-to-equity ratio combined with negative ROE raises financial risk: interest obligations can pressure cash flow and limit strategic flexibility. With losses and cash burn, higher leverage amplifies vulnerability to revenue shocks and constrains investment in capacity or new service lines.
IDT Australia Limited News
IDT FAQ
What was IDT Australia Limited’s price range in the past 12 months?
IDT Australia Limited lowest share price was AU$0.04 and its highest was AU$0.11 in the past 12 months.
What is IDT Australia Limited’s market cap?
IDT Australia Limited’s market cap is AU$16.45M.
When is IDT Australia Limited’s upcoming earnings report date?
IDT Australia Limited’s upcoming earnings report date is Sep 01, 2026 which is in 113 days.
How were IDT Australia Limited’s earnings last quarter?
IDT Australia Limited released its earnings results on Feb 17, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is IDT Australia Limited overvalued?
According to Wall Street analysts IDT Australia Limited’s price is currently Overvalued.
Does IDT Australia Limited pay dividends?
IDT Australia Limited pays a Semiannually dividend of AU$0.008 which represents an annual dividend yield of N/A. See more information on IDT Australia Limited dividends here
What is IDT Australia Limited’s EPS estimate?
IDT Australia Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IDT Australia Limited have?
IDT Australia Limited has 427,425,570 shares outstanding.
What happened to IDT Australia Limited’s price movement after its last earnings report?
IDT Australia Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 25.581%.
Which hedge fund is a major shareholder of IDT Australia Limited?
Currently, no hedge funds are holding shares in AU:IDT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
IDT Australia Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:IDT Sentiment 75%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth AU$58.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-52.80%
12-Months-Change
Fundamentals
Return on Equity
-29.05%
Trailing 12-Months
Asset Growth
-8.11%
Trailing 12-Months
Company Description
IDT Australia Limited
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. It offers analytical method development, stability chambers, and chemistry and microbiology quality control laboratory services. The company also provides project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs, as well as pharmaceutical development services in various dosage forms. In addition, it offers medicinal cannabis products, as well as various contract manufacturing services. The company was founded in 1975 and is headquartered in Boronia, Australia.
Technical Analysis
―
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
―
Cronos Australia Ltd.
―
Options Prices
Currently, No data available
---